Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, January 7, 2021
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
Robert Burns Maintained (AUTL) at Strong Buy with Decreased Target to $13 on, Jan 7th, 2021
Robert Burns of HC Wainwright & Co., Maintained "Autolus Therapeutics plc" (AUTL) at Strong Buy with Decreased Target from $19 to $13 on, Jan 7th, 2021.
Robert has made no other calls on AUTL in the last 4 months.
There is 1 other peer that has a rating on AUTL. Out of the 1 peers that are also analyzing AUTL, 0 agree with Robert's Rating of Hold.
This is the rating of the analyst that currently disagrees with Robert
- Robert Shore of "Redburn Partners" Initiated at Strong Buy on, Wednesday, November 25th, 2020
